Clinical Trial Update: Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of fingolimod (FTY720) in de novo adult renal transplant recipients reports on outcomes in newly transplanted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• GILENYA (FINGOLIMOD HCL)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Transplantation | Phase 2 | Status: COMPLETED